For Immediate Release: April 18, 2023 Español Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA vaccines ...
Israel has prioritised bivalent mRNA booster vaccines for individuals at excessive risk of extreme COVID-19, primarily these aged 65 years or older. NEW DELHI: Vulnerable individuals aged 65 years ...
(*6*) (*4*) For Immediate Release: March 14, 2023 Español Today, the U.S. Food and Drug Administration amended the emergency use authorization (EUA) of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to ...